✅ New API: 6000+ US Stock Options End-of-Day Data with 40+ fields. Learn more

Inhibitor Therapeutics Inc (INTI OTCQB) stock market data APIs

$0.0433 0(0%)
as of September 12, 2025
Try our APIs with free plan!

Inhibitor Therapeutics Inc Financial Data Overview

Price chart is built with Anychart
OpenFigi: BBG000BW**** The data is available with plans that include the Fundamentals API. Check our pricing page for details. CIK: 000104**** The data is available with plans that include the Fundamentals API. Check our pricing page for details.

Inhibitor Therapeutics, Inc., a pharmaceutical development company, develops and commercializes therapeutics for patients with certain cancers and non-cancerous proliferation disorders in the United States. It engages in the development of therapies for prostate and lung cancer utilizing itraconazole; and conducted a positive Phase 2b clinical trial of SUBA-Itraconazole for the treatment of basal cell carcinoma nevus syndrome. The company was formerly known as HedgePath Pharmaceuticals, Inc. and changed its name to Inhibitor Therapeutics, Inc. in August 2019. Inhibitor Therapeutics, Inc. was founded in 1992 and is based in Tampa, Florida.

Prev. Close 0.0433
Open 0.0433
High 0.0433
Low 0.0433
52 wk Range 0.034-0.099
Market Cap 7 421 K
Shares Outstanding 173 M
EPS -0.0038
Beta -0.389

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Inhibitor Therapeutics Inc data using free add-ons & libraries


Get Inhibitor Therapeutics Inc Fundamental Data

Inhibitor Therapeutics Inc Fundamental data includes:

  • Net Revenue:
  • EBITDA:
  • Earnings Per Share:
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Inhibitor Therapeutics Inc Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2025-08-13
  • EPS/Forecast: NaN
GET THE PACKAGE

Get Inhibitor Therapeutics Inc End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE
Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
  • Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat